PROTEIN-BASED REGENERATIVE MEDICINE QURGEN
Live / Registered — Registered (as of 12 Nov 2019)
What this means for you
Registered since 12 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88114313
- Registration number
- 5909817
- Mark type
- Design + words
- Filed
- 12 Sept 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 12 Nov 2019
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Stem cells for medical purposes; Stem cells for veterinary purposes; Veterinary diagnostic reagents
Owner
- QURGEN INC., Detroit, MI, US
- QURGEN INC., Detroit, MI, US
- QURGEN INC., Detroit, MI, US
Prosecution history
- 12 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 11 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Sept 2019 — USE AMENDMENT FILED
- 09 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Sept 2019 — TEAS STATEMENT OF USE RECEIVED
- 23 Apr 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Feb 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2019 — PUBLISHED FOR OPPOSITION
- 06 Feb 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jan 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 22 Jan 2019 — ASSIGNED TO LIE
- 07 Jan 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER